Lower Atrial Fibrillation Risk With Sodium-Glucose Cotransporter 2 Inhibitors Than With Dipeptidyl Peptidase-4 Inhibitors in Individuals With Type 2 Diabetes: A Nationwide Cohort Study

CONCLUSIONS: In this nationwide cohort study of individuals with type 2 diabetes, treatment with SGLT2i was associated with a lower risk of AF compared with treatment with DPP-4i.PMID:38654455 | DOI:10.4070/kcj.2023.0234

Source: Korean Circulation Journal - April 24, 2024 Category: Cardiology Authors: Min Kim Kyoung Hwa Ha Junyoung Lee Sangshin Park Kyeong Seok Oh Dae-Hwan Bae Ju Hee Lee Sang Min Kim Woong Gil Choi Kyung-Kuk Hwang Dong-Woon Kim Myeong-Chan Cho Dae Jung Kim Jang-Whan Bae Source Type: research